Related Experiment Videos

[Endocarditis caused by Candida parapsilosis (para-krusei)]

Archives Des Maladies Du Coeur Et Des Vaisseaux
|October 1, 1983
PubMed

Insights

This case study details Candida Parapsilosis endocarditis in a patient with a mitral valve prosthesis. A multidisciplinary approach involving antifungal therapy and valve replacement successfully managed the infection.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Surgical Innovation

Background:

  • Endocarditis presents a significant risk in patients with prosthetic heart valves.
  • Candida Parapsilosis is an opportunistic fungal pathogen that can cause severe infections.

Observation:

  • A patient with a two-year-old mitral valve prosthesis developed Candida Parapsilosis endocarditis, initially presenting with cerebrovascular accident and pyrexia.
  • The infection led to a perivalvular leak after initial treatment, necessitating a second valve replacement.

Findings:

  • A complex therapeutic strategy combining systemic and local antifungal treatments, iodine irrigation, and staged valve replacements was effective in controlling the infection.
  • Early surgical intervention, alongside appropriate antifungal therapy, is crucial for managing prosthetic valve endocarditis.

Implications:

  • Despite advances, fungal endocarditis carries a high mortality rate, emphasizing the need for preventative measures.
  • Vigilance in the use of invasive devices like intravenous catheters and aerosols, and adherence to antibiotic guidelines, are critical for prevention.

Related Concept Videos